Work

S1778 Comprehensive Analysis of Reported Adverse Events for Risankizumab-Rzaa, Ustekinumab, and Adalimumab in Crohn’s Disease: Unveiling Real-World Safety Insights From Pharmacovigilance Database

Year: 2025

Type: conference-abstract

Source: The American Journal of Gastroenterology

DOI: 10.14309/01.ajg.0001134572.91137.4f

Authors: Yash P. Ashara, Esha Garg, Angy Hanna, Bhavtosh Dedania

Language: English

Topic: Inflammatory Bowel Disease

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4417195586

Cites:

Cited by:

Related to: